Neo-adjuvant chemotherapy with weekly docetaxel (taxotere) in poor prognosis locally-advanced breast cancer (LABC).

被引：0
|
作者：
Bines, J
Vinholes, J
Del Giglio, A
Vasconcelos, A
Cabral, C
Gusmao, C
Martins, RG
Carmo, PAO
机构：
[1] Inst Nacl Canc, Rio De Janeiro, Brazil
[2] Fac Med ABC, Sao Paulo, Brazil
[3] Hosp Sao Rafael, Salvador, BA, Brazil
[4] Hosp Araujo Jorge, Goiania, Go, Brazil
[5] Hosp Nove Julho, Sao Paulo, Brazil
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
166
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [21] Neo-adjuvant anthracycline based chemotherapy in locally advanced breast cancer: assessment of topoisomerase IIA with response
    Singer, J.
    Dewdney, A.
    Mapp, L.
    Bradpiece, H. A.
    Jenkins, S.
    Jader, S.
    Patel, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 311 - 311
  • [22] Strain wave elastography in response assessment to neo-adjuvant chemotherapy in patients with locally advanced breast cancer
    Katyan, Amit
    Mittal, Mahesh Kumar
    Mani, Chinta
    Mandal, Ashish Kumar
    BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1099):
  • [23] Neo-adjuvant Therapy in Locally Advanced Vulvar Cancer
    Rashmi Kumari
    Ava D. Desai
    Bijal M. Patel
    Chetna D. Parekh
    Shilpa M. Patel
    Meeta Mankad
    Indian Journal of Gynecologic Oncology, 2016, 14 (3)
  • [24] Neo-adjuvant Therapy in Locally Advanced Vulvar Cancer
    Kumari, Rashmi
    Desai, Ava D.
    Patel, Bijal M.
    Parekh, Chetna D.
    Patel, Shilpa M.
    Mankad, Meeta
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 14 (03)
  • [25] THE ROLE OF 18FDG-PET/CT AND KI67 IN THE EVALUATION OF EARLY RESPONSE TO NEO-ADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER (LABC).
    Dockx, Y.
    Van den Wyngaert, T.
    Altintas, S.
    Papadimitriou, K.
    Baldewijns, M.
    Van Dam, P.
    Tjalma, W. A.
    Stroobants, S.
    Huizing, M. T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1040 - 1040
  • [26] Differential expressions of immune check point receptors on tumor infiltrating lymphocytes after neo-adjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC)
    Abbasov, Ayxan
    Cetin, Esin
    Cabioglu, Neslihan
    Mollavelioglu, Baran
    Onder, Semen
    Emiroglu, Selman
    Tukenmez, Mustafa
    Muslumanoglu, Mahmut
    Igci, Abdullah
    Deniz, Gunnur
    Ozmen, Vahit
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Docetaxel (Taxotere®) in the neo-adjuvant setting in non-small-cell lung cancer
    Mattson, K
    ANNALS OF ONCOLOGY, 1999, 10 : 69 - 72
  • [28] The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer
    Hirano, A
    Shimizu, T
    Imamura, H
    Watanabe, O
    Kinoshita, J
    Okabe, T
    Kimura, K
    Kamimura, M
    Domoto, K
    Aiba, M
    Ogawa, K
    ANTICANCER RESEARCH, 2006, 26 (1B) : 581 - 584
  • [29] Docetaxel-Induced Peripheral Neuropathy in Breast Cancer Patients Treated with Adjuvant or Neo-Adjuvant Chemotherapy
    Cheng, Hui Lin
    Molassiotis, Alex
    Leung, Anthony Kwun To
    Wong, Kam Hung
    BREAST CARE, 2021, 16 (03) : 269 - 275
  • [30] Prospective phase II study of: neo-adjuvant doxorubicin followed sequentially by cisplatin/docetaxel in locally advanced breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 157 - 157
12345